Effects of COVID-19 on Respiratory System

被引:0
|
作者
Karahalil, Bensu [1 ]
Deniz, Muhammed Ercan [1 ]
Iyigundogdu, Irem [1 ]
Tumer, Miray [1 ]
机构
[1] Gazi Univ, Fac Pharm, Dept Pharmaceut Toxicol, Ankara, Turkey
来源
GAZI MEDICAL JOURNAL | 2020年 / 31卷 / 3A期
关键词
COVID-19; viral entry; ACE2; receptor; respiratory system; SARS-CoV; ARDS; CORONAVIRUS;
D O I
10.12996/gmj.2020.124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronavirus disease 2019 (COVID-19) was caused by a novel type of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was originated in Wuhan, China in December 2019. It spreads rapidly all over the world since respiratory virus infection can occur through many easy ways (e.g. contact, droplet spray, aerosol) and besides, asymptomatic people also have contagiousness. So far, there have been 23,491,520 confirmed cases of COVID-19, including 809,970 deaths, reported to World Health Organization (WHO), which declared it as a significant threat to global health. Fever, fatigue, and dry cough are the commonly observed symptoms in the patients. In COVID-19, the main affected system is respiratory system and some cases demonstrate a rapid progression to acute respiratory distress syndrome (ARDS), while other organs are less involved. Angiotensin-converting enzyme 2 receptor-virus association is essential and responsible for the development of the disease. SARS-CoV-2 causes deaths through its severe effects on the respiratory system.
引用
收藏
页码:528 / 531
页数:4
相关论文
共 50 条
  • [1] COVID-19 and the cardiovascular system: An update
    Salabei, Joshua K.
    Asnake, Zekarias T.
    Ismail, Zeeshan H.
    Charles, Kipson
    Stanger, Gregory-Thomas
    Abdullahi, Abdullahi H.
    Abraham, Andrew T.
    Okonoboh, Peters
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2022, 364 (02): : 139 - 147
  • [2] Renin-Angiotensin System Inhibitors and the COVID-19 Pandemic
    Muchaili, Lweendo
    Mweene, Bislom C.
    Masenga, Sepiso K.
    AMERICAN JOURNAL OF HYPERTENSION, 2023, 36 (07) : 360 - 362
  • [3] Effects of COVID-19 on the Nervous System
    Iadecola, Costantino
    Anrather, Josef
    Kamel, Hooman
    CELL, 2020, 183 (01) : 16 - +
  • [4] COVID-19 in Children: Respiratory Involvement and Some Differences With the Adults
    Jurado Hernandez, Jenny Libeth
    Alvarez Orozco, Ivan Francisco
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [5] Modeling and Simulation of Respiratory System for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
    Awad, Mohamed Elnoby
    El-Garhy, Ahmed M.
    Eldosoky, Mohamed A.
    Soliman, Ahmed M.
    PROCEEDINGS OF 2021 38TH NATIONAL RADIO SCIENCE CONFERENCE (NRSC), 2021, : 232 - 242
  • [6] Respiratory and cardiovascular effects of COVID-19 infection and their management
    Kapoor, Mukul Chandra
    JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY, 2020, 36 : S21 - S28
  • [7] Extra-respiratory manifestations of COVID-19
    Lai, Chih-Cheng
    Ko, Wen-Chien
    Lee, Ping-Ing
    Jean, Shio-Shin
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (02)
  • [8] COVID-19 and the nervous system
    Berger, Joseph R.
    JOURNAL OF NEUROVIROLOGY, 2020, 26 (02) : 143 - 148
  • [9] COVID-19 and the Cardiovascular System
    Veer, Manik
    Kumar, Aarthi Madhana
    Ivanova, Valentyna
    CRITICAL CARE NURSING QUARTERLY, 2020, 43 (04) : 381 - 389
  • [10] Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19
    Cavalcanti, Iago Dillion Lima
    Medeiros, Sandrelli Meridiana de Fatima Ramos dos Santos
    Macedo, Daniel Charles dos Santos
    Cavalcanti, Isabella Macario Ferro
    Nogueira, Mariane Cajuba de Britto Lira
    CURRENT DRUG DELIVERY, 2021, 18 (05) : 583 - 595